Are you Dr. Parrilla Castellar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-3074
Summary
- Dr. Edgardo Parrilla Castellar, MD is a board certified pathologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, North Carolina, and Minnesota. He is an Assistant Professor at U of WA Sch of Med.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Molecular Genetic Pathology, 2012 - 2013- Mayo Clinic College of Medicine and Science (Rochester) Surgical PathologyFellowship, Selective Pathology, 2011 - 2012
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2008 - 2011
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2006 - 2008
University of Puerto Rico School of MedicineClass of 2006
Certifications & Licensure
PR State Medical License 2011 - 2025
MN State Medical License 2011 - 2024
NC State Medical License 2015 - 2024
WA State Medical License 2013 - 2015- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 3 citationsDo Histopathology and Clinical Outcomes of Breast Atypia Vary by Race/Ethnicity?Amanda R. Sergesketter, Samantha M. Thomas, Edgardo R. Parrilla Castellar, Oluwadamilola M. Fayanju, Carolyn S. Menendez
The Journal of Surgical Research. 2020-11-01 - 21 citationsDisparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast CancerCosette D. Champion, Samantha M. Thomas, Jennifer K. Plichta, Edgardo R. Parrilla Castellar, Laura H. Rosenberger
JCO Oncology Practice. 2020-10-07 - 5 citationsSomatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.Edgardo R. Parrilla Castellar, Jennifer K. Plichta, Richard C. Davis, Claudia P. Gonzalez-Hunt, Laurie H. Sanders
The American Journal of Pathology. 2020-09-12
